Highnoon Laboratories Limited is proud to announce a strategic partnership with Beximco Pharmaceuticals Limited, a leading pharmaceutical manufacturer based in Bangladesh. This alliance marks a significant milestone in Highnoon’s international expansion strategy, aimed at bringing advanced technologies, therapies, and novel dosage forms to the Pakistani market. Both companies are listed on the stock exchanges in their respective countries.

This partnership will focus on the distribution, marketing, and sales of specialized pharmaceutical products in Pakistan, with an emphasis on respiratory, diabetes, and cardiovascular therapeutic segments. The collaboration is designed to strengthen Highnoon’s portfolio in these high-impact areas, providing a competitive edge through innovative drug delivery systems and clinical advancements.
This collaboration also reflects the strengthening economic ties between Pakistan and Bangladesh, reinforcing a shared vision for regional cooperation in healthcare and trade.